Developing and testing an online pathway from screening to treatment for depression in oncology: iPath*D

Principal Investigator

Paul Barr

Study Number

STUDY02001240

Summary

The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.

Phase

0

Available at the following location(s)

• Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms